智通财经网·2025-08-12 12:50Core Viewpoint - Fudan Zhangjiang (01349) reported a decline in revenue and profit for the first half of 2025, primarily due to increased R&D expenses and the impact of a previous partnership termination with a service provider [1] Financial Performance - Revenue for the period was approximately 390 million yuan, representing a year-on-year decrease of 4.42% [1] - Shareholders' profit amounted to 5.715 million yuan, reflecting a significant year-on-year decline of 91.89% [1] - Earnings per share were reported at 0.0055 yuan [1] Factors Influencing Performance - The decline in profit was attributed to an increase in R&D expenses compared to the same period last year [1] - The previous year's termination of cooperation with the promotional service provider, Huizheng (Shanghai) Pharmaceutical Technology Co., Ltd., led to the recognition of corresponding compensation and penalty fees [1]